Andrew J. Einhorn's Net Worth
$279 Thousand
Who is Andrew J. Einhorn?
Andrew J. Einhorn does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include RVL Pharmaceuticals plc, Edge Therapeutics, Inc., MYOS Corp, and COGNITION THERAPEUTICS INC.
SEC CIK
Andrew J. Einhorn's CIK is 0001560685
Past Insider Trading and Trends
2015 was Andrew J. Einhorn's most active year for acquiring shares with 8 total transactions. Andrew J. Einhorn's most active month to acquire stocks was the month of September. 2015 was Andrew J. Einhorn's most active year for disposing of shares, totalling 5 transactions. Andrew J. Einhorn's most active month to dispose stocks was the month of September. 2015 saw Andrew J. Einhorn paying a total of $523,935.08 for 125,248 shares, this is the most they've acquired in one year. In 2020 Andrew J. Einhorn cashed out on 9,184 shares for a total of $64,288.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
RVL Pharmaceuticals plc (RVLPQ) Snapshot price: $0.0003
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -6.36% | -9.61K |
$1.13 | -$10,855.91 | 141.47K |
Jan 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 4
| |||
Form 4
| -4.10% | -6.47K |
$3.12 | -$20,177.04 | 151.08K |
May 18
| |||
Form 4
| -5.78% | -9.67K |
$4.46 | -$43,119.28 | 157.55K |
Jan 24
| |||
Form 4
| +74.79% | 71.55K |
—
|
—
| 167.22K |
May 18
| |||
Form 4
| -8.76% | -9.18K |
$7.00 | -$64,288.00 | 95.67K |
Jan 28
| |||
Form 4
|
∞
| 104.85K |
—
|
—
| 104.85K |
Jan 24
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Edge Therapeutics, Inc. (PDSB) Snapshot price: $5.27
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +3.76% | 1.57K |
$2.39 | $3,745.13 | 43.22K |
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
∞
| 125.25K |
$8.84 |
—
| 125.25K |
Oct 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MYOS Corp (MDVL) Snapshot price: $3.1
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
COGNITION THERAPEUTICS INC (CGTX) Snapshot price: $2.24
Interim CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||